Group ACYW135 Meningococcal Conjugate Vaccine

Meningococcal conjugate vaccine ACYW135 · Sinovac Biotech Co., Ltd

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Group ACYW135 Meningococcal Conjugate Vaccine, covering 2015-06-25 to 2026-08-10. Get the full timeline:

Most recent: Clinical Trial Update: Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years [Phase 3]